U.S. Software Stock News

Astera Labs recently announced major enhancements to its Scorpio X-Series for AI infrastructure and hyperscale data centers, while investors await the company’s fourth-quarter earnings report scheduled for February 10, 2026. The product refresh, which adds higher radix support, in-network computing, hypercast technology, and optical connectivity tailored to individual hyperscalers, underscores Astera Labs’ focus on reducing integration barriers for complex AI workloads. With these Scorpio...

Ormat Technologies (ORA) is back on investors’ radar after a strong 1 year total return of 89.93%, prompting a closer look at how its geothermal, recovered energy and storage operations are shaping the story. See our latest analysis for Ormat Technologies. Recent trading has cooled after a strong run, with a 1 day share price return of 4.37% and a 7 day share price return of 5.28% pulling back some of the 89.93% 1 year total shareholder return. The latest 30 day and 90 day share price returns...

Transocean’s recent fleet status report and earnings call highlighted unusually high earnings visibility, with management emphasizing transparent rig deployment and day-rate data available to investors. Management also signaled strong optimism about offshore day rates and anticipated long-term contracts at materially higher mid-$500,000-per-day levels than many market expectations. We’ll now examine how management’s confidence in securing higher day-rate, long-term contracts could...

Seacoast Banking Corporation of Florida reported fourth-quarter 2025 results, with net interest income rising to US$174.63 million and net income holding steady at about US$34.26 million, while basic earnings per share from continuing operations declined to US$0.32. The quarter also featured strong 15% annualized loan growth, higher noninterest income including US$550 million of new wealth management assets, improved cost efficiency, and sharply lower net charge-offs of US$936,000 compared...

If you are wondering whether Ingersoll Rand shares still offer value at current levels, this article will walk through what the numbers are really saying about the stock. The share price recently closed at US$96.00, with returns of 8.0% over 7 days, 15.1% over 30 days, 20.4% year to date, 4.0% over 1 year, 70.6% over 3 years, and 119.1% over 5 years. These figures may affect how you think about upside and risk today. Recent attention on Ingersoll Rand has focused on how the share price...

Adobe (ADBE) is back in focus after a sharp sector-wide selloff tied to concerns that new artificial intelligence tools could chip away at traditional software moats and long term business models. See our latest analysis for Adobe. Those AI worries have translated into weak momentum, with a 1 month share price return of 19.82% decline and a year to date share price return of 19.17% decline. The 1 year total shareholder return sits at a 38.13% loss, pointing to pressure that has built over...

In recent weeks, Resideo Technologies has been recognized for product innovation, winning two 2026 IoT Breakthrough Awards for its Honeywell Home X8S smart thermostat and First Alert CX4 video cameras, while also preparing to report its fourth quarter and full year 2025 results on February 24, 2026. This combination of third-party validation for its smart home and security offerings and commentary around improving operational fundamentals is sharpening investor focus on how Resideo is...

Hycroft Mining Holding (HYMC) has drawn attention after reporting the highest silver grades yet identified in its Vortex Silver System, alongside drilling that points to resource continuity and a sharp move in the share price. See our latest analysis for Hycroft Mining Holding. Those drilling results and stronger bullion sentiment have come alongside sharp swings in HYMC, with a recent 1 day share price return of 14.22% decline and a 7 day share price return of 26.26% decline, set against a...

Market context for Baidu (NasdaqGS:BIDU) Baidu (NasdaqGS:BIDU) has drawn attention after recent share price moves, with a gain over the past 3 months and a decline over the past month and year to date. Investors are weighing these mixed signals. See our latest analysis for Baidu. Baidu’s recent moves tell a mixed story, with a 10.32% 90 day share price return contrasting with a 7.54% year to date share price decline and a 56.47% 1 year total shareholder return. This suggests earlier momentum...

RBC Bearings: recent performance snapshot RBC Bearings (RBC) has attracted fresh attention after a strong price move in recent months, with the shares recently closing at $520.16. For context, the stock shows a 9.3% return over the past month and 19.8% over the past 3 months. See our latest analysis for RBC Bearings. That recent momentum sits on top of a wider trend, with a 13.4% year to date share price return and a 42.4% total shareholder return over the past year, suggesting that interest...

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if...

CF Industries Holdings (CF) is drawing fresh attention after launching a low carbon fertilizer pilot with POET and several major farm cooperatives, tying its nitrogen products directly to cleaner corn and ethanol production. See our latest analysis for CF Industries Holdings. These low carbon efforts sit alongside recent shareholder friendly moves, such as the declared US$0.50 per share dividend payable in late February 2026, and come after a recent analyst reassessment that kept CF...

If you are wondering whether Antero Resources' current share price lines up with its underlying value, you are not alone. This article is built to help you size that up calmly and clearly. The stock last closed at US$33.85, with returns of 4.8% over 30 days, a 1.1% decline year to date, an 11.6% decline over 1 year, and a 26.2% gain over 3 years. These mixed returns sit against a backdrop of ongoing attention on US energy producers and commodity exposed names, where investor sentiment can...

Arcutis Biotherapeutics reported positive Phase 2 topline results for ZORYVE cream in infants with atopic dermatitis. The study focused on a vulnerable pediatric group that currently has limited treatment options. For investors watching Arcutis Biotherapeutics, NasdaqGS:ARQT, the latest ZORYVE update adds new context to a share price of $26.07. The stock has returned 109.9% over the past year and 57.7% over the past 3 years, while the 5 year return stands at a 25.1% decline. Short term...

If you are wondering whether Fastenal shares still offer value after a strong run, this article will walk through what the current price might be implying. The stock recently closed at US$47.33, with recorded returns of 9.2% over 7 days, 16.5% over 30 days, 17.0% year to date, 30.9% over 1 year, 95.6% over 3 years and 125.3% over 5 years. This naturally raises questions about what is already priced in. Recent attention on Fastenal has centered on its role as an industrial and construction...

American Superconductor (AMSC) just posted Q3 2026 results that put the spotlight on its income statement, with revenue of US$74.5 million and basic EPS of US$2.68 anchored by net income of US$117.8 million. The company has seen revenue move from US$61.4 million in Q3 2025 to US$74.5 million in Q3 2026, while quarterly EPS shifted from US$0.07 to US$2.68, highlighting a period where reported profitability and wider margins are front and center for investors assessing how durable this earnings...

If you are wondering whether Take-Two Interactive Software's current share price lines up with its underlying worth, this article will walk through what the numbers are really saying about value. The stock last closed at US$193.24 after a 19.2% decline over the past week and a 24.0% decline over the past month, even though the 1 year return sits at 5.5% and the 3 year return at 74.3%. These moves have come as attention has stayed on Take-Two's position in major gaming franchises and its...

In late January 2026, Comcast reported fourth-quarter 2025 results showing higher revenue but lower quarterly net income year over year, affirmed its annual dividend at US$1.32 per share, and confirmed ongoing share repurchases under a buyback program that has retired more than 40% of its stock since 2012. At the same time, Comcast’s spin-off of its linear cable networks and renewed focus on NBCUniversal, Peacock, broadband, and theme parks has drawn attention to potential value unlocking at...

Regions Financial (RF) has drawn fresh investor attention after its board approved by-law changes that expand shareholder rights and, at the same time, declared new cash dividends on both common and preferred shares. See our latest analysis for Regions Financial. Those governance changes and fresh dividends come as the shares trade at US$30.50, with a 90 day share price return of 22.74% and a 1 year total shareholder return of 29.16%. This suggests that momentum has been building over both...

If you are wondering whether Microchip Technology is priced attractively today, the key question is how its current share price lines up against the value of its underlying business. The stock last closed at US$78.04, with returns of 2.8% over 7 days, 5.5% over 30 days, 20.0% year to date and 55.1% over 1 year, which may have changed how some investors think about its risk and return profile. Recent coverage has focused on Microchip Technology in the context of the broader semiconductor...

Apple (NasdaqGS:AAPL) is shutting down its standalone AI health coach project, known internally as Mulberry. The company plans to roll out AI driven coaching tools gradually within its existing Health app instead of launching a separate product. This change reflects a focus on user safety and regulatory requirements in digital health and AI. For you as an investor looking at Apple beyond iPhones and Macs, health and wellness sit alongside services, wearables and software as part of the...

If you are wondering whether ZoomInfo Technologies is starting to look like value or a value trap, the stock’s recent performance gives you plenty to think about. The share price closed at US$6.78, with returns of a 17.2% decline over the past week, a 35.4% decline over the past month, a 29.4% decline year to date, a 34.1% decline over the past year, a 75.4% decline over three years, and an 88.1% decline over five years. Recent news flow around ZoomInfo has focused on its position in the...

If you are wondering whether AnaptysBio's share price still lines up with its underlying worth, you are not alone. That is exactly what this article will unpack. AnaptysBio's stock most recently closed at US$47.90, with returns of 0.1% over 7 days, 9.1% over 30 days, 6.6% year to date, 197.9% over 1 year, 84.6% over 3 years and 45.1% over 5 years. This performance has naturally raised questions about how the current price compares to its fundamentals. Recent attention on AnaptysBio has been...

UGI (UGI) has opened its 2026 financial year with Q1 revenue of about US$2.1b and basic EPS of US$1.38, alongside net income excluding extraordinary items of US$297m. Over recent quarters the company has seen revenue move between US$1.2b and US$2.7b, while basic EPS has ranged from a loss of US$1.27 per share to a high of US$2.23 per share. This gives investors a wide band of recent earnings outcomes to weigh. With trailing 12 month EPS at US$2.79 on net income of US$600m, the latest quarter...